Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Abstract Nonalcoholic fatty liver disease (NAFLD) is the primary cause of chronic liver disease in the United States, afflicting an estimated 80 to 100 million Americans. Nonalcoholic fatty liver disease is a spectrum of liver diseases composed of nonalcoholic fatty liver and nonalcoholic steatohepa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Mayo Clinic proceedings 2015-09, Vol.90 (9), p.1233-1246
Hauptverfasser:	Spengler, Erin K., MD, Loomba, Rohit, MD, MHSc
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers - blood Biopsy Biopsy - utilization Care and treatment Decision Support Techniques Diagnosis Fatty liver Female Humans Internal Medicine Liver Liver - pathology Liver Function Tests Male Non-alcoholic Fatty Liver Disease - diagnosis Non-alcoholic Fatty Liver Disease - epidemiology Non-alcoholic Fatty Liver Disease - pathology Non-alcoholic Fatty Liver Disease - therapy Practice guidelines (Medicine) Referral and Consultation - statistics & numerical data Risk Factors United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!